scispace - formally typeset
D

David A. Cooper

Researcher at Pfizer

Publications -  965
Citations -  81765

David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.

Papers
More filters

Extended nevirapine prophylaxis to prevent HIV transmission

TL;DR: Hopefully, the START study, which compares starting cART with a CD4 cell count above 500 cells per μL versus deferring to a CD 4 cell count of less than 350 cells perμL, will provide the evidence base to bridge the gap so elegantly closed by the ART-CC group.
Reference EntryDOI

AIDS: Understanding HIV Transmission

TL;DR: For the implementation of successful prevention and intervention strategies in order to reduce HIV transmission and reduce the spread of HIV infection, it is essential to understand the variables associated with different modes of HIV transmission.
Journal ArticleDOI

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings

TL;DR: In this paper, a set of random forest models were trained using very large, global datasets to predict either the probability of virological response (classifier models) or the absolute change in viral load in response to a new regimen (absolute models).
Journal ArticleDOI

Sexual activity of HIV patients.

TL;DR: The topic of sexual activity among HIV patients was examined in a comparative study of HIV antibody-positive patients in Ireland and Australia, carried out between June and December 2005.